Literature DB >> 17032661

The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function.

T B Corcoran1, A Engel, H Sakamoto, A O'Shea, S O'Callaghan-Enright, G D Shorten.   

Abstract

BACKGROUND: Coronary artery bypass grafting (CABG) with cardiopulmonary bypass elicits a potent reperfusion injury and inflammatory response, more intense in patients with impaired myocardial function. Propofol has antioxidant properties which may attenuate such a response.
METHODS: In total, 27 patients with impaired left ventricular function undergoing CABG were randomly allocated to receive either target-controlled infusion propofol (P) or saline (S) immediately before aortic cross-clamp release until 4 h after reperfusion. Troponin-I, Urinary 8-epi PGF-2alpha isoprostane, coronary sinus and systemic malondialdehyde concentrations, Interleukin-6 (IL-6), -8 and -10 concentrations and leucocytes function studies (neutrophil respiratory burst, phagocytosis, CD-11b and CD-18 expression) were measured.
RESULTS: Propofol decreased MDA coronary sinus concentration at 1, 3 and 5 min after reperfusion (P<0.01); 60 min after reperfusion a significant difference between the two groups in systemic MDA concentrations was also seen. IL-6 concentration increases were significantly greater in Group S than Group P, 4 h after reperfusion [1118 (1333) pg ml(-1) vs 228 (105) pg ml(-1), P<0.01]. Serum IL-8 concentrations did not increase significantly in either group. Compared with baseline values IL-10 concentrations decreased after reperfusion but the values were higher in the propofol group than in the control group [22 (16) vs 11 (4) pg ml(-1), P<0.05]. No difference in leucocyte function or urinary isoprostane concentrations was demonstrated.
CONCLUSION: Propofol attenuates free-radical-mediated lipid peroxidation and systemic inflammation in patients with impaired myocardial function undergoing CABG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17032661     DOI: 10.1093/bja/ael270

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  24 in total

1.  Protective effect of propofol and its relation to postoperation recovery in children undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  Wen-fang Xia; Yu Liu; Qing-shan Zhou; Qi-zhu Tang; Han-dong Zou
Journal:  Pediatr Cardiol       Date:  2011-06-03       Impact factor: 1.655

Review 2.  Anesthesia, surgery, illness and Alzheimer's disease.

Authors:  Roderic G Eckenhoff; Krzysztof F Laudansky
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-06-21       Impact factor: 5.067

Review 3.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

4.  Comparison of inflammatory cytokine profiles in plasma of patients undergoing otorhinological surgery with propofol or isoflurane anesthesia.

Authors:  Marina Azer Mazoti; Mariana Gobbo Braz; Márjorie de Assis Golim; Leandro Gobbo Braz; Norimar Hernandes Dias; Daisy Maria Favero Salvadori; José Reinaldo Cerqueira Braz; Denise Fecchio
Journal:  Inflamm Res       Date:  2013-06-22       Impact factor: 4.575

5.  Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery.

Authors:  Wen-fang Xia; Yu Liu; Qing-shan Zhou; Qi-zhu Tang; Han-dong Zou
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

6.  Variation in Sedation and Neuromuscular Blockade Regimens on Outcome After Cardiac Arrest.

Authors:  Teresa L May; Richard R Riker; Gilles L Fraser; Karen G Hirsch; Sachin Agarwal; Christine Duarte; Hans Friberg; Eldar Søreide; John McPherson; Robert Hand; David Kent; Niklas Nielsen; David B Seder
Journal:  Crit Care Med       Date:  2018-10       Impact factor: 7.598

7.  Propofol inhibits pressure-stimulated macrophage phagocytosis via the GABAA receptor and dysregulation of p130cas phosphorylation.

Authors:  Hiroe Shiratsuchi; Yasser Kouatli; Guang Xiang Yu; Harold M Marsh; Marc D Basson
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-08       Impact factor: 4.249

8.  Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation.

Authors:  Baohua Wang; Jayant Shravah; Honglin Luo; Koen Raedschelders; David D Y Chen; David M Ansley
Journal:  Biochem Biophys Res Commun       Date:  2009-08-22       Impact factor: 3.575

9.  Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion.

Authors:  Nicola King; Madj Al Shaama; M-Saadeh Suleiman
Journal:  Pflugers Arch       Date:  2012-09-22       Impact factor: 3.657

10.  Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas Anesthesia for Pancreatic Cancer Surgery.

Authors:  Jose M Soliz; Ifeyinwa C Ifeanyi; Mathew H Katz; Jonathan Wilks; Juan P Cata; Thomas McHugh; Jason B Fleming; Lei Feng; Thomas Rahlfs; Morgan Bruno; Vijaya Gottumukkala
Journal:  Anesth Pain Med       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.